Swissray International has begun installing the first of its AddOn-Buckyx-ray digitization devices. Three units will be installed at theLangental Hospital in Switzerland, with placement of the firstAddOn-Bucky scheduled for late February. Swissray, of
Swissray International has begun installing the first of its AddOn-Buckyx-ray digitization devices. Three units will be installed at theLangental Hospital in Switzerland, with placement of the firstAddOn-Bucky scheduled for late February.
Swissray, of Hitzkirch, Switzerland, introduced U.S. audiencesto AddOn-Bucky at last year's Radiological Society of North Americameeting (SCAN 12/13/95). The device is a cassette-style buckythat retrofits to conventional x-ray units for digitizing x-raystudies.
The company also reported this month that it has completedan equity placement that raised $4.5 million. The funds will beused for sales and marketing and acquisitions.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.